drugset / Trial / NCT02805608
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The sensitivity and specificity of uPAR PET/CT with the radioligand 68GaNOTA-AE105 and FDG PET/MRI for preoperative detection of regional lymph node metastases in urinary bladder cancer
Timeline
- Start
- 2016-09
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | — | Intravenous |
| Subject | 68Ga-NOTA-AE105 | Peptide | — | Intravenous |